Antibody Responses in Early Human Immunodeficiency Virus Type 1 Infection in Hemophiliacs
Overview
Affiliations
Sera from hemophiliacs were analyzed for antibodies to human immunodeficiency virus type 1 (HIV-1) by using radioimmunoprecipitation (RIP), western blotting (WB) with nonreducing buffer (NR), and WB with reducing buffer (R). We analyzed envelope gp160, gp120, and gp41; pol gene proteins p64, p53, and p34; and gag gene protein p24. Of 215 samples positive for reactivity to gp160 and gp120(RIP), antibodies to p24 were undetectable in 2 (0.9%), to gp41 in 9 (4.2%), to the pol antigens in 5 (2.3%), to gp120(NR) in 3 (1.4%), and to gp120(R) in 55 (25.6%). By sequential analysis of samples, antibodies to gp120(NR), gp120(R), p24, gp41, p64/53, and p34 were observed later in the course of infection than were antibodies to gp120(RIP) or gp160. This result suggests caution against reliance on WB as the "gold standard." A significantly higher rate of progression to AIDS-related complex was found for individuals lacking antibodies to gp120(R). It is possible that antigenic domains represented by gp120(R) may play a role in the pathogenesis of HIV-1 infection.
Biomarkers predicting progression of human immunodeficiency virus-related disease.
Kanekar A J Clin Med Res. 2011; 2(2):55-61.
PMID: 21811520 PMC: 3140879. DOI: 10.4021/jocmr2010.03.255w.
Ozyoruk F, Cheevers W, Hullinger G, McGuire T, Hutton M, Knowles D Clin Diagn Lab Immunol. 2001; 8(1):44-51.
PMID: 11139194 PMC: 96009. DOI: 10.1128/CDLI.8.1.44-51.2001.
Hochleitner E, Borchers C, Parker C, Bienstock R, Tomer K Protein Sci. 2000; 9(3):487-96.
PMID: 10752610 PMC: 2144561. DOI: 10.1110/ps.9.3.487.
BRODIE S, Pearson L, Snowder G, DeMartini J Arch Virol. 1993; 130(3-4):413-28.
PMID: 8390828 DOI: 10.1007/BF01309670.
Chargelegue D, OToole C, Colvin B Clin Exp Immunol. 1993; 93(3):331-6.
PMID: 8370162 PMC: 1554909. DOI: 10.1111/j.1365-2249.1993.tb08181.x.